PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing Cholangitis

WIND-PSC will enroll up to 2000 patients with primary sclerosing cholangitis (PSC) across North America and Europe Study designed in collaboration with top global PSC experts and aligned with regulatory guidance for using real-world data to develop new treatments in rare diseases First patient-led clinical research project of its kind in liver diseases and launched […] Read The Rest at :